Table 1 Demographic data of covid 19 patients
From: Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients
|  | NSCP group(n = 28) | SCP group (n = 70) |  |
|---|---|---|---|
Median [IQR] | Median [IQR] | P | |
Age (Years) (n, %) (Mean ± SD) | 59.4 ± 15.0 | 63.9 ± 13.2 | 0.143 |
Sex (n, %) | |||
 Male | 12, 42.9% | 27, 38.6% |  |
 Female | 16, 57.1% | 43, 61.4% | 0.695 |
Symptoms | |||
 Dyspnea | 14, 50.0% | 50, 71.4% | 0.044 |
 Dry Cough | 14, 50.0% | 36, 51.4% | 0.898 |
 Productive Cough | 10, 35.7% | 19, 27.1% | 0.401 |
 Fatigue | 14, 50.0% | 34, 48.6% | 0.898 |
 Bone Aches | 10, 35.7% | 27, 38.6% | 0.792 |
 Fever | 18, 64.3% | 38, 54.3% | 0.366 |
 Diarrhea | 6, 21.4% | 13, 18.6% | 0.747 |
 Anorexia | 4, 14.3% | 9, 12.9% | 0.851 |
 Taste Loss | 7, 10.0% | 6, 21.4% | 0.132 |
 Smell Loss | 6, 8.6% | 4, 14.3% | 0.399 |
 Vomit | 8, 28.6% | 14, 20.0% | 0.358 |
 Sore Throat | 0, 0.0% | 5, 7.1% | 0.147 |
 Chest Pain | 2, 7.1% | 5, 7.1% | 1.000 |
 Nausea | 0, 0.0% | 2, 2.9% | 0.366 |
O2 Saturation (n, %) | |||
 < 87% | 0, 0.0% | 58, 82.9% |  |
 > 87% | 28, 100.0% | 12, 17.1% |  < 0.001 |
Radiological CO-RAD Category (n, %) | |||
 CO-RADs 4 | 10, 35.7% | 10, 14.3% |  |
 CO-RADs 5 | 18, 64.3% | 60, 85.7% | 0.017 |
Survival (n, %) | |||
 Dead | 4, 14.3% | 32, 45.7% |  |
 Survived | 24, 85.7% | 38, 54.3% | 0.004 |